Activation of Atypical PKC by Insulin and Other Agonists
Description: These findings will provide new avenues for finding treatments for the metabolic syndrome and type 2 diabetes, which together are estimated to cause at least 50% of the cardiovascular disorders seen in the US population, and which are exceedingly costly health issues.
Funding type: research
Funder scheme: R01
Start date: 2004-07-01
End date: 2016-09-30
Investigator: ROBERT V FARESE
Institution: TAMPA VA RESEARCH AND EDUCATION FDN
Funded outputs count: 68
Funder award ID: R01DK065969
OpenAlex ID: G4836743404